Discover the latest research on screening and diagnosis of fetal anomalies: heart at ISUOG 2026.

Affecting eight in 1000 newborns, congenital heart disease is the most prevalent fetal abnormality worldwide. Nearly half of infant mortality is attributable to cardiac defects. Advances in prenatal ultrasound imaging have transformed detection, shifting diagnosis to earlier in the antenatal period, thereby enabling perinatal planning, targeted follow-up, and informed parental counselling. Despite these advances, significant variation persists in the standard of clinical practice. There remains no universal consensus on indications for fetal echocardiography, with marked discrepancies in how risk factors are interpreted and applied. Furthermore, detection rates continue to vary globally, reflecting differences in expertise, training and resource availability.

ISUOG's global awareness initiative, Every Little Heart Matters, has been introduced to help raise awareness of the varying detection rates and clinical standards across the globe, and help provide clear research-driven guidance to clinicians on how to best diagnose fetal heart anomalies. ISUOG strives to help close the gaps in detection rates with the disemination of education, clinical guidelines and resources as Every Little Heart Matters, no matter where it is in the world.

Considering this, the 36th ISUOG World Congress in London will offer a unique opportunity to receive much-needed research updates, hear directly from international experts in ultrasound and fetal cardiology, and explore the controversies shaping current practice. Through cutting-edge sessions and expert-led discussions that span global perspectives, attendees will gain the knowledge and skills required to ensure precise diagnoses, harmonised clinical approaches, and ultimately improved outcomes for infants and their families worldwide.
 

Why is fetal anomalies: heart a key topic at ISUOG 2026?

At the ISUOG World Congress, fetal cardiology takes center stage bringing together the latest advances in cardiac imaging science with ISUOG’s global mission to improve outcomes for babies everywhere. The Congress will showcase cutting‑edge research in fetal cardiac screening, advanced echocardiography, artificial intelligence, and emerging technologies that are reshaping how congenital heart disease is detected and managed worldwide. Alongside this scientific innovation, ISUOG proudly highlights its global awareness initiative, Every Little Heart Matters, a campaign dedicated to improving early detection of congenital heart disease and promoting equity in access to high‑quality prenatal imaging. Through education, advocacy, and patient‑centered storytelling, the initiative empowers clinicians to recognize abnormal hearts with confidence and reinforces the principle that early diagnosis can change lives. Together, advanced science and global advocacy converge at the ISUOG Congress uniting experts, educators, and innovators around a shared goal: ensuring that every pregnancy benefits from the best possible cardiac imaging, because every little heart matters.

Dr Helen Feltovich

Sessions where you can learn more about this topic at ISUOG 2026 World Congress

We are still finalising the Congress Scientific program. Please come back later to see which sessions you can attend to learn more about the fetal heart.

 

Supplement your learning before the congress

Recent UOG articles

UOG videos

 

Lectures

 

ISUOG guideline

 

VISUOG

Abnormal 4-chamber views main pic.JPG1

Abnormal 4-chamber view

Explore chapters on the abnormal 4 chamber view.

Abnormal outflow tracts main pic.JPG

Abnormal outflow tracts

Explore chapters on aortic stenosis, common arterial trunk, fallots & variants, TGA, c-TGA, and pulmonary stenosis.

Abnormal 3-vessels view main pic.JPG

Abnormal 3-vessels view

Explore chapters on persistent left superior vena cava, aberrant right subclavian artery, double aortic arch and right aortic arch.

Abnormal Beats.jpg 1

Abnormal Rate and Rhythm

Explore chapters on abnormal rate and rhythm, fetal tachycardia and fetal bradycardia.

 

VISUOG Case

 

Patient information

Hypoplastic Left Heart Syndrome (HLHS)

This leaflet is to help you understand what Hypoplastic Left Heart Syndrome (HLHS) is, what causes it, and the implications of being diagnosed for you, your baby, and your family.

Transposition of the Great Arteries (TGA)

This leaflet is to help you understand TGA and what questions you need to ask your doctor.

Coarctation of the aorta

This leaflet is to help you understand what Coarctation of the aorta is, what tests you need and the implication of being diagnosed with Coarctation of the aorta for your baby and your family.

Total Anomalous Pulmonary Venous Return (TAPVR)

This leaflet is to help you understand what total anomalous pulmonary venous return (TAPVR) is and what causes it, what tests you need, and the implications of being diagnosed for your baby once it is born.

Ebstein’s anomaly

This leaflet is to help you understand what Ebstein’s anomaly is, what tests you need, and the implication of being diagnosed for your baby and your family.

Common Arterial Trunk

This leaflet is to help you understand what Common Arterial Trunk is, what tests you need and the implication of having been diagnosed with Common Arterial Trunk for you, your baby and your family.

 

CME activities

Key questions

What are the optimal ultrasound imaging protocols in the first, second and third trimesters for accurate detection of congenital heart disease?

How can standardised cardiac views be optimised using Doppler to improve detection rates across varying levels of operator experience?

Which sonographic findings should trigger referral for fetal echocardiography or additional imaging?

Why do expert recommendations differ on indications for fetal echocardiography, and how should clinicians navigate areas of consensus versus controversy in daily practice?

Register for the ISUOG World Congress to get answers to these questions. 

Share